In a recent paper in the Journal of the National Cancer Institute,
clinical biochemist Eleftherios Diamandis uncovers some of bigger
blunders in cancer-diagnosis techniques -- explaining how experimental
data could be misinterpreted and how, as a result, once-touted
breakthroughs turned out to be far less than met the eye. Diamandis
spoke to TIME earlier this week about his findings, and about how
fizzled hopes can affect medicine
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.